Vaccines List

M-001 Influenza Vaccine

M-001 vaccine is a recombinant protein containing 9 conserved epitopes from Influenza A and B that are common to the vast majority of influenza viruses.Read more...

M-M-R II Vaccine

M-M-R II vaccine is also known as Measles, Mumps, and Rubella Virus Vaccine Live, is a live virus MMR vaccine.Read more...

MenABCWY Meningococcal (PF-06886992) Vaccine

Pfizer’s pentavalent meningococcal vaccine candidate (PF-06886992) combines its two approved meningococcal vaccines, Nimenrix™ (meningococcal group A, C, W-135, and Y conjugate vaccine) and Trumenba® (meningococcal group B vaccine).Read more...

Menactra Meningococcal Vaccine

Menactra contains N meningitidis serogroup 8 A, C, Y and W-135 capsular polysaccharide antigens individually conjugated to diphtheria toxoid 9 protein. N meningitidis A, C, Y, and W-135 strains are cultured on Mueller Hinton agar and 10 grown in Watson Scherp media containing casamino acid.Read more...

Meningococcal Vaccines

Meningococcal vaccines prevent illness caused by bacteria called Neisseria meningitidis, also known as meningococcus. These illnesses are often severe and can be deadly.Read more...

Menveo Meningococcal Vaccine

Menveo consists of two portions: 10 µg of lyophilized meningococcal serogroup A capsular polysaccharide conjugated to CRM197 and 5 μg each of capsular polysaccharide of serogroup C, W, and Y conjugated to CRM197 in 0.5 mL of phosphate-buffered saline, which is used to reconstitute the lyophilized MenA component.Read more...

MK-7110 COVID-19 Therapeutic

MK-7110 (CD24Fc) COVID-19 Therapeutic candidate is a first-in-class recombinant fusion protein that targets the innate immune system.Read more...

Molnupiravir (MK-4482, EIDD-2801) Antiviral

Molnupiravir (MK-4482, EIDD-2801) is an investigational, orally bioavailable form of a potent ribonucleoside analog that inhibits the replication of multiple RNA viruses including SARS-CoV-2, the causative agent of COVID-19.Read more...

Mosquirix RTS-S/AS01 Malaria Vaccine

Mosquirix (RTS,S/AS01) is a recombinant vaccine candidate consisting of the P. falciparum circumsporozoite protein (CSP) from the pre-erythrocytic stage.Read more...

mRNA-1010 Quadrivalent Influenza Vaccine

Modern, Inc.'s mRNA-1010 Quadrivalent Influenza Vaccine candidate targets the WHO flu lineages recommendationsRead more...

mRNA-1345 Respiratory Syncytial Virus (RSV) Vaccine

mRNA-1345 Respiratory Syncytial Virus (RSV) Vaccine candidate encodes for a prefusion F glycoprotein, which elicits a superior neutralizing antibody response.Read more...

mRNA-1647 Cytomegalovirus Vaccine

mRNA-1647 is designed to produce an immune response to both pentamer and gB antigens to prevent CMV infection.Read more...

mRNA-1653 hMPV+PIV3 Vaccine

mRNA-1653 is a combination vaccine that consists of two distinct mRNA sequences encoding the fusion (F) proteins of hMPV and PIV3 formulated in Moderna’s proprietary lipid nanoparticle (LNP) technology.Read more...

mRNA-1893 Zika Vaccine

mRNA-1893 contains an mRNA sequence encoding for the structural proteins of the Zika virus and is designed to cause cells to secrete virus-like particles, mimicking the response of the cell after natural infection.Read more...

mRNA-1944 Chikungunya Vaccine

Moderna's mRNA-1944 encodes a fully human IgG antibody originally isolated from B cells of a patient with a prior history of potent immunity against Chikungunya infection.Read more...

mRNA-4157 Cancer Vaccine

Moderna's mRNA-4157 is a therapeutic cancer vaccine candidate that is a combination of validated defined neoantigens, predicted neoepitopes, and mutations in driver genes into a single mRNA concatemer (mRNA-4650).Read more...

MRT5400/MRT5401 mRNA Influenza Vaccine

MRT5400 and MRT5401 are mRNA Influenza Vaccine candidates that have entered a phase 1 clinical trial.Read more...

MRT5500 mRNA Vaccine

Translate Bio and Sanofi MRT5500 is an mRNA SARS-CoV-2 vaccine candidateRead more...

MV-CHIK Chikungunya Vaccine

MV-CHIK is a vaccine candidate utilizing Themis’ measles vector platform. MV-CHIK consists of a recombinant live Schwarz-strain measles-vectored vaccine expressing chikungunya virus structural proteins.Read more...

MV-LASV Lassa Fever Vaccine

MV-LASV vaccine candidate is a recombinant, live-attenuated, viral vectored vaccine, based on the backbone of the measles Schwarz virus strain for prophylaxis of Lassa infectionRead more...

MVA MERS-S Vaccine

MVA-MERS-S (Modified Vaccinia virus Ankara) is a vaccine candidate that contains the full-length spike gene of MERS-CoV.Read more...

MVA-M1+NP Influenza A Vaccine

MVA-M1+NP vaccine candidate consists of MVA, a replication-deficient pox viral vector that has been safely tested in thousands of patients, to generate a strong immune reaction against Matrix 1 (M1) and Nucleoprotein (NP) influenza antigens. Read more...

MVX-ONCO-1 Cancer Immunotherapy Vaccine

MVX-ONCO-1 is an anti-cancer therapy based upon triggering the patient's own natural immune responseRead more...